Skip to content

13F-HR filed by MACKENZIE FINANCIAL CORP

MACKENZIE FINANCIAL CORP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-04-24, with 1,513 holding rows worth $64,738,467,128.

Accession
0001062993-23-009485
Filed
2023-04-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 1,533 entries on the cover page, a total value of $64,738,467,128 stated on the cover page (in dollars after the unit check, H1), rows summing to $64,738,467,128 with VALUE read as dollars as filed, 13F file number 028-05178. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
22ND CENTY GROUP INC90137F103COM11,265$8,663dollars as filed
MULLEN AUTOMOTIVE INC62526P109COM64,087$8,415dollars as filed
NEKTAR THERAPEUTICS640268108COM11,940$8,393dollars as filed
LORDSTOWN MOTORS CORP54405Q100COM10,423$6,911dollars as filed
WHEELS UP EXPERIENCE I F96328L106Com10,377$6,567dollars as filed
CENNTRO ELECTRIC GROUP LIMITQ6519V120COM12,533$5,788dollars as filed
HYCROFT MINING HOLDING CORP44862P109COM10,393$4,494dollars as filed
VINCO VENTURES INC927330100COM12,445$3,999dollars as filed
SEMA4 HOLDINGS CORP81663L101COM10,223$3,731dollars as filed
BRIDGEBIO PHARMA INC09077J107COM11,769$3,294dollars as filed
BRIGHT HEALTH GROUP INC10920V107COM12,580$2,771dollars as filed
VISTAGEN THERAPEUTICS INC92840H202COM13,730$1,712dollars as filed
HEADHUNTER GROUP PLC ADR42207L106COM20,330$0dollars as filedValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062993-23-009485this filing2023-04-24acceptance time not in the bulk data set